Navigation Links
Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
Date:1/29/2013

ment in treadmill exercise time (ETT) to a more objective efficacy endpoint of reduction in reversible perfusion deficit based on SPECT myocardial perfusion imaging.  Similar to mechanical/surgical cardiac revascularization approaches, the goal of Generx treatment is to improve myocardial perfusion (blood flow).  SPECT myocardial perfusion imaging can be used to quantitatively evaluate Generx's effectiveness by measuring improved myocardial blood flow under stress, a key prognostic indicator that is associated with the regenerative process of new collateral vessel formation in and around the regions of ischemia.  While walking time during ETT has been a traditional efficacy measure of anti-anginal drugs, it is based on a subjective assessment of chest pain (angina pectoris), does not directly measure improvements in cardiac blood flow, and can be affected by other variables.  Positive results from the prior Phase 2a clinical study (Grines et al., J Am Coll Cardiol 2003; 42:1339-47) showed that Generx improved myocardial blood flow in the ischemic region of the hearts of patients following a single intracoronary infusion as measured by the objective efficacy endpoint of SPECT imaging.  The observed treatment effect for patients receiving Generx was similar in magnitude to that reported in the literature for patients undergoing angioplasty/stent or revascularization procedures with reversible perfusion defects of comparable size at one year following these procedures.

ASPIRE Study

The ASPIRE study is a 100-patient, randomized and controlled multi-center study currently enrolling patients at up to eight leading cardiology centers in the Russian Federation.  The ASPIRE study is designed to further evaluate the safety and effectiveness of Cardium's Generx DNA-based angiogenic product candidate, which has already been tested in clinical studies involving 650 patients at more than one hundred medical centers in the U.S., <
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
2. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
3. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
4. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
5. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
6. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
7. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
8. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
9. Medisafe 1 Technologies Announces the Ex-Dividend Date on April 30 2013, Record Date on May 3 2013 and the Payment Date on May 6 2013
10. Beckers Hospital Review Announces Members of 2013 Advisory Board
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... 2011 Actavis Group, the international generic pharmaceuticals company, today ... a binding letter of intent (LOI) with QRxPharma Limited (ASX: ... United States.  Under the terms of the ... IR, a patented 3:2 ratio fixed dose combination of morphine ...
...  QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution ... for the formation of a strategic partnership to commercialise MoxDuo ... IR is a patented 3:2 ratio fixed dose combination of ... Group, hf a privately held company based in Europe with ...
Cached Medicine Technology:Actavis to Launch Novel Pain Medication in the US 2Actavis to Launch Novel Pain Medication in the US 3QRxPharma Announces Strategic Partnership with Actavis 2QRxPharma Announces Strategic Partnership with Actavis 3QRxPharma Announces Strategic Partnership with Actavis 4QRxPharma Announces Strategic Partnership with Actavis 5
(Date:12/21/2014)... HealthDay Reporter FRIDAY, Dec. 19, ... addictive than traditional cigarettes, new research finds. Even ... cigarettes, thousands of ex-smokers said they have fewer cravings and ... need to smoke, researchers reported. "The pattern ... e-cig use than for tobacco use," said lead researcher Jonathan ...
(Date:12/21/2014)... Parker & Sons, Inc. a market leader in ... similar home contractor services announces a record number of ... contracting services. The company is considered by many to ... for well over 40 years. Parker and Sons takes ... customer service to the residents and business owners of ...
(Date:12/21/2014)... 21, 2014 CannabisClassifieds.com celebrates marijuana’s new legal ... only one of its kind, the site has provided its ... for 14 years running. It uniquely combines the benefits ... cannabis readily available to the masses. Assuring the potent ... golden ring of public approval. , Shane Chattin, ...
(Date:12/20/2014)... MissyDress, a distinguished special dress supplier, has just ... has drastically cut prices to all its prom dresses ... 30, 2015. Many of the hottest styles are sold ... dresses, and more. , A spokesman for MissyDress says, ... A-line princess prom dresses or sweetheart chiffon prom dresses, ...
(Date:12/20/2014)... The print component of Healthy Aging is distributed ... 160,000 copies and an estimated readership of 420,000. The ... media strategy and across a network of top news ... of the campaign, click here . , The ... of CTV’s The Social. Lainey Lui, Melissa Grelo, ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2
... , , SALT LAKE CITY, ... instrument company focused on unique silicon nitride ceramic technologies, announced today ... global headquarters. , , Bucking the national trend, ... the new larger multifunctional facility. Amedica believes the new space ...
... , , , , ... The Mount Sinai Medical Center has joined with Long Island Heart ... surgical cardiovascular care to patients on Long Island. , , ... Associates made it an ideal match for our cardiovascular center of ...
... , , CHICAGO, ... the H1N1 virus - the upcoming revisit of swine flu - ... plans within the private sector. "There,s no question that companies have ... are navigating a daunting market and obstacles not immediately in their ...
... , BOSTON, Sept. 10 Purchasers of ... a rollback of benchmark prices of some of the most ... affirmed the approval of a settlement with two leading drug-pricing ... Kluwer Health, Inc. , , (Logo: ...
... , , LOS ANGELES, Sept. 10 ... into DietTribe , Lifetime,s reality series about a group of friends ... premieres Friday, October 2nd at 9:00pm ET/PT . ... return to guide and coach an all-new tribe as they work towards ...
... CHICAGO, Sept. 10 The following is a statement by Lenore Janecek, ... As this debate rages on about medical reform, patient safety organizations, those of ... what is happening to the people from the senseless health care devastation throughout ... million people in the U.S. died needlessly in the past ten ...
Cached Medicine News:Health News:Amedica Announces New Global Headquarters 2Health News:Expanded Cardiovascular Care Services on Long Island 2Health News:H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 2Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 2Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 3Health News:Major Rollback of Pharmaceutical Bench Mark Prices Approved by Federal Court of Appeals, Hagens Berman Announces 4Health News:Get Pumped Up for the Return of 'DietTribe' Season Two of Inspirational Lifestyle Series Premieres October 2 on Lifetime Television 2Health News:Get Pumped Up for the Return of 'DietTribe' Season Two of Inspirational Lifestyle Series Premieres October 2 on Lifetime Television 3Health News:Medical Holocaust in U.S.: Who in the Health Cares? 2Health News:Medical Holocaust in U.S.: Who in the Health Cares? 3
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: